|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 K Street NW, Suite 100 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2399 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 4493-12
|
||||||||
|
6. House ID# 312430000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Matthew Shick |
Date | 4/20/2017 4:10:13 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
No activity
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Presidents Budget, FY 2017 (amended supplemental request)
S. 3040/H.R. 5916 Labor, HHS, Education and Related Agencies Act, 2017, Title II
Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Oppose rescissions from the Center for Medicare and Medicaid Innovation and Patient Centered Outcomes Research Trust Fund. Oppose additional continuing resolutions. Oppose cuts to NIH and health professions programs to fund Administrations supplemental request. Support funding for Department of Education and federal student aid.
FY 2017 Budget Reconciliation
Issue: Repeal and replace of the ACA. Oppose elimination of Prevention and Public Health Fund
Presidents Budget, FY 2018
Issues: Support funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Oppose cuts to NIH, including limitations on facilities and administrative reimbursement. Maintain NIH salary cap at Executive Level II. Oppose reorganization of NIH and AHRQ without stakeholder input and deliberation. Support funding for Health Resources and Services Administration (HRSA) and Title VII and Title VIII health professions and nursing education programs. Support funding for Veterans Affairs medical research, research infrastructure, and community care. Support funding for Department of Education and federal student aid.
P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of Innovation Fund.
Issue: Support non-defense discretionary spending
Issue: Support mandatory funding for the National Health Service Corps (NHSC) authorized under P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; oppose use of Medicare GME funding for creation of new GME grant program. Oppose Independent Payment Advisory Panel (IPAB) and site-neutral payment policy.
Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Clayton |
Crabtree |
|
|
|
Catherine |
Spivey |
|
|
|
Josepth |
Banez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
no activity
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Issues: Oppose cuts to graduate/professional student loan benefits, including Public Service Loan Forgiveness (PSLF).
S. 850 / H.R.1922, Foreign Medical School Accountability Fairness Act of 2017
Issue: Support transparency for all international medical schools.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Joseph |
Banez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1628 American Health Care Act
Issue: ACA repeal and replace legislation and Medcaid per capita cap and block grant provisions.
S. 455 Restoring Rural Residencies Act of 2017
Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.
Issue: Educate congressional staff on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.
Issue: Repeal and replace of Affordable Care Act. Support continuation high-quality affordable health insurance through preservation of current levels of health care coverage. Support programs and funds for safety-net providers.
Issue: Reauthorization of Title VII health professions programs
Issue: Training in substance abuse, pain management. Strategies to prevent, identify, and treat opioid dependence
Issue: 340B Drug Pricing Program
Issue: Support the Hospitals Preparedness Program
Issue: Affirm the safety of vaccines
Issue: Support the Patient Centered Outcomes Research Institute (PCORI)
P.L. 114-255, 21st Century Cures Act
Issue: Support Implementation of 21st Century Cures Act
Issue: Promote resilience of health professionals
Issue: Regulation of Laboratory Developed Tests
Issue: Potential nominations for presidential appointments
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Clayton |
Crabtree |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Catherine |
Spivey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Executive Orders 13769 and 13780
Issue: Oppose travel suspension from affected countries and suspension of visa interview waiver program. Support policies to ensure timely and predictable processing for immigration of academic medicine community.
Issue: Support policies allowing undocumented students to attend U.S. medical schools and residency training. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement, such as the Development, Relief, and Education for Alien Minors (DREAM) Act. Support DREAMer eligibility for federal student loans.
S.128/H.R.496, Bar Removal of Individuals who Dream and Grow our Economy (BRIDGE) Act
Issue: Support provisional protected presence for DACA eligible individuals.
S. 898, Conrad State 30 and Physician Access Act
Issue: Support reauthorization and expansion of the Conrad 30 J-1 visa waiver program for physicians.
Issue: Oppose suspension of H-1B visa premium processing. Support exception of cap-exempt higher education and related institutions from suspension.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), State - Dept of (DOS), Health & Human Services - Dept of (HHS), U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of 21st Century Cures Act, including increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.
Issue: Regulation of Laboratory Developed Tests
FY 2018 Presidents Budget
Issue: Oppose limitations on facilities and administrative reimbursement.
Issue: Provide comments on revision to the Common Rule
Issue: Support NIH medical research of pain and addiction
Submitted comments to:
AHRQ in response to a request for information regarding Learning Healthcare Systems (LHS)
NIH in response to a request for information on strategies for NIH data management, sharing, and citation
17. House(s) of Congress and Federal agencies Check if None
Office of Management & Budget (OMB), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Clayton |
Crabtree |
|
|
|
Len |
Marquez |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Joseph |
Banez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments
Issue: Oppose reduction of Medicare GME/IME payments
Issue: Oppose inclusion of Medicare add-on payments in Hospital-Acquired Condition (HAC) program.
Issue: Oppose Medicare hospital cuts
Issue: Support Medicare Graduate Medical Education (GME) per resident amount technical corrections and administrative relief.
Issue: Support legislation providing three full years of federal Medicaid matching funding to states that expand Medicaid
Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.
Issues: Support extension of the Childrens Health Insurance Program (CHIP)
Issue: Development and implementation of new Medicare Disproportionate Share Hospital (DSH) formula required under the ACA.
Issue: Support allowing providers in new delivery models (e.g., ACOs, bundled payments, etc.) to access medical records with information on substance use disorders
Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs
Issue: Medicaid Section 1115 and 1332 Waivers
Issue: ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers. Delay Medcaid DSH cuts.
Issue: Nominations for Medicaid and CHIP Payment and Access Commission (MACPAC) new commissioners
Submitted comments to:
CMS on AAMC regulatory priorities regarding, quality, GME and IME payments, MACRA, alternative payment models, fraud and abuse, and other issues of concern
CMS on the Market Stabilization Proposed Rule
CMS on comment on the Medicare Appeals Process
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Catherine |
Spivey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Issue: Support the use of a competitive peer review process for federal research grants and programs
P.L. 114-329, American Innovation and Competitiveness Act
Issue: Support reauthorization of NSF, including NSFs merit-bases peer review process and reducing regulatory burden on scientists
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
RASOULI |
|
|
|
Clayton |
Crabtree |
|
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issue: Support improved contracting with academic affiliates
Issue: Support increased VA GME funding and Medicare GME funding for VA affiliates
Issue: Support authority for VA joint ventures with academic affiliates
Issue: Support VA Plan to Consolidate Community Care Programs, including the proposed Core Network and sole source contracting with academic affiliates.
Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships.
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
no activity
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |